Wexford Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,800	Closed	-$361K	–	195
2017 Q2	$361K	Buy	+2,800	New	+$361K	0.03%	130
2013 Q4	–	Sell	-3,500	Closed	-$265K	–	273
2013 Q3	$265K	Buy	+3,500	New	+$265K	0.02%	185